TRGM Insider Trading Activity and SEC Form 4 Filings
TRGM insider trading summary
No open-market insider purchases or sales of Targeted Medical Pharma, Inc. (TRGM) have been reported on SEC Form 4 in the past 12 months.
Latest TRGM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 24, 2015 | Olena B. Giffoni | 10% Owner | Sell | $129 (8,580 @ $0.01) |
| Nov 24, 2015 | Giffoni Family Trust Dated September 26 2008 | 10% Owner | Sell | $129 (8,580 @ $0.01) |
| Nov 24, 2015 | Kim Giffoni | Chief Executive Officer | Sell | $129 (8,580 @ $0.01) |
| Nov 24, 2014 | Kim Giffoni | EVP Foreign Sales/Inv. Rel. | Buy | $250 (500 @ $0.50) |
| Nov 24, 2014 | Giffoni Family Trust Dated September 26 2008 | 10% Owner | Buy | $250 (500 @ $0.50) |
| Nov 24, 2014 | Olena B. Giffoni | 10% Owner | Buy | $100 (200 @ $0.50) |
| Nov 24, 2014 | Olena B. Giffoni | 10% Owner | Buy | $250 (500 @ $0.50) |
| Nov 24, 2014 | Kim Giffoni | EVP Foreign Sales/Inv. Rel. | Buy | $100 (200 @ $0.50) |
| Nov 24, 2014 | Giffoni Family Trust Dated September 26 2008 | 10% Owner | Buy | $100 (200 @ $0.50) |
| Aug 12, 2014 | Elizabeth Charuvastra Exemption Trust | CEO & Chief Scientific Officer | Sell | $40K (101,035 @ $0.40) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.